Catalase activity significantly decreased in cancer stages 2, 3, and 4 compared to the control group (p = 0.0001, 0.0001, and 0.0002, respectively), although no significant difference was noted between stage 1 and the control group (p > 0.05). The gene discussed is CAT; the disease is cancer.